- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
AIM Vaccine Co Ltd (6660)
AIM Vaccine Co Ltd stock price live, this page displays HK 6660 stock exchange data. View the 6660 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the AIM Vaccine Co Ltd real time stock price chart below.
What Is the AIM Vaccine Co Ltd Stock Price Today?
The AIM Vaccine Co Ltd stock price today is 2.29.
What Is the Stock Symbol for AIM Vaccine Co Ltd?
The stock symbol for AIM Vaccine Co Ltd is "6660."
What Stock Exchange Does AIM Vaccine Co Ltd Trade On?
AIM Vaccine Co Ltd is listed and trades on the Hong Kong stock exchange.
Is AIM Vaccine Co Ltd a Good Stock to Buy?
Determining whether AIM Vaccine Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6660 quote. (ISIN: CNE100005KF2)
What Is the AIM Vaccine Co Ltd Stock Price Today?
The AIM Vaccine Co Ltd stock price today is 2.29.
What Is the Stock Symbol for AIM Vaccine Co Ltd?
The stock symbol for AIM Vaccine Co Ltd is "6660."
What Stock Exchange Does AIM Vaccine Co Ltd Trade On?
AIM Vaccine Co Ltd is listed and trades on the Hong Kong stock exchange.
Is AIM Vaccine Co Ltd a Good Stock to Buy?
Determining whether AIM Vaccine Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6660 quote. (ISIN: CNE100005KF2)
Hong Kong
Currency in HKD
2.29
-0.09(-3.78%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.25
2.40
52 wk Range
2.25
6.01
Unusual trading volume
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.252.40
52 wk Range
2.256.01
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
6660 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
11.50
Upside
+402.31%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
AIM Vaccine Co., Ltd. engages in the research and development, manufacture, and sale of vaccine products for human use in the People’s Republic of China. The company’s product pipeline includes tetravalent meningococcal conjugate vaccine, which is in phase IV clinical trial for meningococcal disease 13-Valent pneumonia conjugate and 23-valent pneumonia polysaccharide vaccine to treat pneumonia; iterative serum-free rabies vaccine; and bivalent Delta-Omicron BA.5 mRNA COVID-19 vaccine that is in phase III clinical trial to treat COVID-19 infection. It also offers tetravalent meningococcal polysaccharide and conjugate vaccine, which is in phase II trials for the treatment of meningococcal disease; and EV71-CA16 Bivalent HFMD vaccine. In addition, the company develops 20-valent and 24-valent pneumonia conjugate vaccine, haemophilus influenzae type b conjugate vaccine, absorbed tetanus vaccine, quadrivalent influenza virus vaccine (MDCK Cells), and human diploid rabies vaccine. Further, it offers hexavalent meningococcal vaccine to treat meningococcal disease; hexavalent group b streptococcus polysaccharide conjugate vaccine; mRNA human rabies vaccine; mRNA Shingles/Herpes Zoster vaccine; mRNA respiratory syncytial virus vaccine; diphtheria, tetanus, pertussis and haemophilus influenzae type b, and acellular pertussis combination vaccine for the treatment of DTP; and recombinant group B meningococcal vaccine to treat meningococcal disease. The company was formerly known as Beijing AIM Biological Vaccine Technology Group Co., Ltd. and changed its name to AIM Vaccine Co., Ltd. in September 2020. The company was incorporated in 2011 and is headquartered in Beijing, the People’s Republic of China.
Compare 6660 to Peers and Sector
Metrics to compare | 6660 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6660PeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.8x | −17.2x | −0.5x | |
PEG Ratio | 0.03 | 0.01 | 0.00 | |
Price/Book | 0.9x | 4.1x | 2.6x | |
Price / LTM Sales | 2.2x | 22.8x | 3.2x | |
Upside (Analyst Target) | 383.4% | 38.4% | 45.2% | |
Fair Value Upside | Unlock | −4.8% | 6.4% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 11.50
(+402.31% Upside)
Earnings
Latest Release
Mar 30, 2026
EPS / Forecast
-0.44 / --
Revenue / Forecast
651.02M / --
FAQ
What Is the AIM Vaccine (6660) Stock Price Today?
The AIM Vaccine stock price today is 2.29 HKD.
What Stock Exchange Does AIM Vaccine Trade On?
AIM Vaccine is listed and trades on the Hong Kong Stock Exchange.
What Is the Stock Symbol for AIM Vaccine?
The stock symbol for AIM Vaccine is "6660."
What Is the AIM Vaccine Market Cap?
As of today, AIM Vaccine market cap is 2.81B HKD.
What Is AIM Vaccine's Earnings Per Share (TTM)?
The AIM Vaccine EPS (TTM) is -0.55.
From a Technical Analysis Perspective, Is 6660 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has AIM Vaccine Stock Split?
AIM Vaccine has split 0 times.
How Many Employees Does AIM Vaccine Have?
AIM Vaccine has 1466 employees.
What is the current trading status of AIM Vaccine (6660)?
As of Apr 23, 2026, AIM Vaccine (6660) is trading at a price of 2.29 HKD, with a previous close of 2.29 HKD. The stock has fluctuated within a day range of 2.25 HKD to 2.40 HKD, while its 52-week range spans from 2.25 HKD to 6.01 HKD.
What Is AIM Vaccine (6660) Price Target According to Analysts?
The average 12-month price target for AIM Vaccine is 11.50 HKD, with a high estimate of 11.50298302 HKD and a low estimate of 11.50298302 HKD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +402.31% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.